On October 30, 2026, DEA posted DEA Medical Marijuana Timely Applicant Information, a four-page document explaining how qualifying medical cannabis businesses can operate while their federal registration applications are pending. It addresses who they can buy from and sell to, what records they should collect, and how to handle existing inventory and laboratory testing.
That document is the October 30 guidance discussed below. DEA also maintains a separate list of timely applicants. The guidance explains the federal framework; the list gives us a snapshot of participation. Together, they raise a practical question: are enough businesses eligible to participate for existing cannabis supply chains to keep functioning?
The main point: Having your own qualifying application or DEA registration is only part of the picture. The businesses you buy medical cannabis from and sell it to also need the appropriate federal status. DEA expects Timely Applicants to verify those relationships and establish compliant supply chains by November 29, 2026.
The guidance concerns covered Schedule III medical marijuana activities. It does not provide general permission for adult-use operations. It also states that it explains existing legal requirements and Department of Justice policies and does not itself have the force and effect of law.
Who qualifies as a Timely Applicant?
A Timely Applicant submitted both a completed application and the applicable registration fee between April 28 and June 26, 2026, inclusive. Its application must still be pending, and it must hold the required state medical marijuana license. Filing during that window without paying the fee does not qualify.
Qualifying applicants may continue the dispensing, manufacturing or distribution activities covered by their applications and state medical licenses while DEA reviews their applications. Withdrawal, a final denial order or loss of the required state license ends eligibility for this pending-applicant authority. Guidance, paragraphs 1–4
Who can these businesses buy from and sell to?
For the covered commercial cannabis transactions, the guidance identifies two eligible groups: qualifying Timely Applicants and DEA registrants authorized to handle Schedule III medical marijuana. For example, a registered dispensary can receive product from a qualifying Timely Distributor Applicant. Both businesses do not need to have received their registrations already.
A business that applied late, submitted an incomplete application or never applied must obtain the appropriate DEA registration before participating in these transactions. A late application that is still pending is not enough. These distinctions concern commercial suppliers and buyers; they do not mean patients must obtain DEA registration.
DEA says transactions with an ineligible business could provide grounds to deny an application or revoke a registration. That makes a supplier’s or buyer’s status relevant to your own business. Federal eligibility also does not replace the state-law limits on the transaction. Guidance, paragraphs 5–8; 21 U.S.C. § 822(c)(3)
What DEA expects businesses to check
The guidance describes the following as minimum due diligence during the transition. These checks apply to the commercial businesses involved in your covered medical cannabis transactions.
- For a Timely Applicant: obtain its DEA submission confirmation and verify its document control number, or DCN, through DEA’s website. For dispensers, the confirmation is called “Marijuana Dispensary Information Submission.”
- For a DEA registrant: obtain a copy of its DEA registration certificate.
- For each business: obtain the relevant state license and verify that it is active.
- Keep the records: retain evidence of the documents collected and verification performed.
My practical recommendation is to add these materials to your existing vendor and customer files, recording when each check occurred, who performed it and what the source showed. DEA registrants must also maintain the applicable federal records under Part 1304. For transactions with a Timely Applicant, those records may use the applicant’s DCN where a DEA registration number would otherwise be required. Guidance, paragraphs 8–9
What November 29 means
DEA expects Timely Applicants to verify their trading partners, make necessary changes and establish compliant supply chains by November 29, 2026. Paragraph 11 does not expressly give already registered businesses that same transition period. The date also does not provide blanket permission to keep making new purchases from ineligible suppliers until then.
There is a separate allowance for existing inventory. Timely Dispenser Applicants and Timely Distributor Applicants may continue using covered inventory acquired before the October 30 guidance was issued, including inventory obtained from businesses outside the eligible group, in otherwise authorized activities. This allowance does not cover new purchases or expressly extend to manufacturers.
Businesses relying on that allowance should identify the affected lots and preserve records showing when they acquired them. The guidance does not set a separate sell-through or destruction date for that qualifying inventory. Guidance, paragraph 11
Laboratory testing has a narrow exception
Analytical laboratories do not receive the Timely Applicant exception. DEA nevertheless recognizes that some businesses may lack access to a laboratory with the required federal registration.
The guidance describes limited enforcement discretion for sending very small, or de minimis, testing quantities to a state-licensed, non-DEA-registered laboratory in the same state, with detailed shipment records. It applies only if no laboratory anywhere in the United States has the relevant DEA registration, or if state law prohibits out-of-state testing shipments and no laboratory in the business’s state has that registration.
This is not a general registration exemption, and it does not permit the business to receive cannabis back from the unregistered laboratory. California businesses need to verify the applicable shipment restrictions and registered-laboratory availability before relying on this provision. The guidance alone does not establish that the exception applies to a particular shipment. Guidance, paragraph 10 and footnote 1
The applicant list raises the bigger question
The October 30 version of DEA’s timely-applicant list contains 6,983 application entries nationwide. California accounts for 771: 491 dispensary applications, 198 manufacturer applications and 82 distributor applications. Federal manufacturing includes cultivation, so growers are included within that federal activity category. 21 U.S.C. § 802(15), (22)
Those figures need context. The list covers timely applications, rather than everyone who has applied. DEA explains that entries leave the list when registrations are granted, applications are withdrawn or status otherwise changes. A business missing from the list may already hold a registration. Application entries also are not necessarily unique businesses.
California has thousands of cannabis licenses, as reflected in the Department of Cannabis Control’s licensing dashboard. That is a different measure from DEA application entries, so the comparison cannot tell us what percentage of businesses or trading relationships qualify. It does, however, highlight why businesses need to examine their actual supply chains.
A dispensary may qualify but find that important suppliers do not. A cultivator may qualify but lose access to buyers. Replacing those relationships takes more than locating another name on a list. The replacement needs the right products, services, capacity and commercial terms.
Prices could be affected too. Fewer eligible buyers could put downward pressure on what suppliers receive. Fewer eligible suppliers could raise retailers’ purchasing costs. Both pressures could occur in the same supply chain, squeezing margins in a market already dealing with price compression.
What businesses should do now
Start with your own federal status, then check the suppliers and commercial buyers you depend on. Collect the documents described above, identify relationships that need to change, and review whether the inventory and testing provisions apply to your operation. If you are a Timely Applicant, build that work around DEA’s November 29 expectation.
My concern remains whether businesses can make this transition while continuing to operate. The October 30 guidance explains who can participate and what DEA expects them to verify. It does not establish that enough eligible suppliers, distributors, laboratories and buyers exist to support the market. Until businesses have a realistic way to keep obtaining inventory, fulfilling contracts and finding customers, I have difficulty describing the system as workable.
Keep reading
Attorney advertising. This article provides general information, not legal advice about a particular business or application. Reading it does not create an attorney-client relationship. It discusses guidance and application data dated October 30, 2026; later developments may change the analysis.